Status:
COMPLETED
Chuna Manual Treatment for Patients With Primary Dysmenorrhea Primary Dysmenorrhea
Lead Sponsor:
Jaseng Medical Foundation
Conditions:
Primary Dysmenorrhea
Eligibility:
FEMALE
14-49 years
Phase:
NA
Brief Summary
This study is a randomized controlled trial that compares 30 patients with primary dysmenorrhea by assigning them in a 1:1 ratio between patients treated with a Chuna therapy strategy and patients tre...
Detailed Description
Menstrual pain is known to be caused by increased tension in the uterine muscles and irregular contractions, and is experienced by 50% of women who menstruate. However, most people control pain with N...
Eligibility Criteria
Inclusion
- Patients whose menstrual pain is NRS 5 or higher during the last 3 months due to primary dysmenorrhea
- Patients who are between 14 and 49 years of age
- Patients whose cycle has been regular between 21 and 40 days for the past 3 months
- Patients who agree to participate in clinical research and provide written test subject consent
Exclusion
- Patients whose cause of menstrual pain is determined to be an organic problem (uterine fibroids, adenomyosis, endometriosis, etc.) rather than a primary cause.
- Patients who have taken oral contraceptives or other hormonal therapy within the past 3 months.
- Patients diagnosed with other chronic diseases (stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.) that may interfere with the treatment effect or interpretation of results.
- Patients who are currently taking steroids, immunosuppressants, drugs for mental illness, or other drugs that may affect the results of the study.
- Patients for whom manual therapy is inappropriate or unsafe: history of lumbar fusion or pelvic girdle surgery, spinal fracture, or severe instability.
- Pregnant women, those planning to become pregnant within 6 months, and those planning to take hormones such as oral contraceptives.
- Patients who finished participating in another clinical study less than 1 month ago, or who plan to participate in another clinical study during the study participation and follow-up period within 6 months from the date of selection.
- Patients who find it difficult to fill out the consent form for research participation.
- Other cases where participation in clinical research is deemed difficult by the researcher.
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06517108
Start Date
January 10 2022
End Date
March 20 2025
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Daejeon Jaseng Hospital of Korean Medicine
Daejeon, South Korea, 35262